Engelhardt

Prof. Dr. Dr. Stefan Engelhardt

Founder and CSO, rnatics

Day2, July 6, 12:30 p.m., Session B:
The bavarian therapeutic strategy to combat the COVID 19 pandemic

Institute of Pharmacology and ToxicologyTechnical University Munich
Position Full Professor (W3) and Chair

Advanced Professional Positions
since 2021 Vice-Coordinator of the Munich site within the German Center for
Cardiovascular Research (DZHK)
since 2019 Coordinator of the Collaborative Research Centre TRR/SFB 267 “Non-coding RNA in the cardiovascular system”
2013-2019 Vice Dean for Research, TUM School of Medicine
2011-2020 Coordinator of the Munich site within the German Center for Cardiovascular Research (DZHK)
2011-2013 Member of the Executive Board of the German Cardiac Society (DGK)
2010-2013 Vice-Chair and Chair (2011) of the Commission for Experimental Cardiology of the German Cardiac Society (DGK)

Professional Experience and Postdoctoral Training
since 2008 Full Professor and Chair (W3), Institute of Pharmacology and Toxicology, Technical University Munich (TUM)
2005-2008 Professor of Clinical Pharmacology at the University of Wuerzburg (W2)
2004-2008 Group Leader, Rudolf Virchow Center, DFG-Research Center for Experimental Biomedicine, University of Wuerzburg
2003-2004 Appointment as Fellow in Cardiovascular Research, Massachusetts General Hospital, Harvard Medical School, Boston
1999-2003 Postdoctoral position at the Institute for Pharmacology and Toxicology,
Bayerische Julius-Maximilians-Universität Wuerzburg

Academic Education
1997-2001 PhD thesis, MD/PhD-program of the faculties of Biology and Medicine,
University of Wuerzburg (summa)
1993-1995 MD thesis, Max-Planck-Institute of Biochemistry, Laboratory of Molecular Biology, Martinsried (summa)
1989-1996 Studies in Medicine, Universities of Regensburg, Munich (Germany) and Harvard (USA)

speichern